CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jul. 01, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Sales		$ 6,465,346	$ 5,972,101	$ 12,224,898	$ 11,446,278
Costs and expenses:
Cost of sales		5,641,380	5,173,310	10,641,045	9,898,589
Selling, general, and administrative expenses		532,347	518,704	1,047,866	1,024,517
Depreciation and amortization		37,381	40,389	74,522	81,322
Restructuring, integration, and other charges		24,416	16,106	39,921	36,894
Total Costs and Expenses		6,235,524	5,748,509	11,803,354	11,041,322
Operating income		229,822	223,592	421,544	404,956
Equity in earnings of affiliated companies		724	2,227	1,649	4,083
Gain on sale of investment		750	0	750	0
Loss on extinguishment of debt		58,759	0	58,759	0
Interest and other financing expense, net		42,358	39,024	80,431	74,599
Income before income taxes		130,179	186,795	284,753	334,440
Provision for income taxes		29,575	51,457	68,799	92,510
Consolidated net income		100,604	135,338	215,954	241,930
Noncontrolling interests		925	1,068	2,507	1,425
Net income attributable to shareholders		$ 99,679	$ 134,270	$ 213,447	$ 240,505
Net income per share:
Basic		$ 1.12	$ 1.46	$ 2.40	$ 2.62
Diluted	[1]	$ 1.11	$ 1.45	$ 2.37	$ 2.59
Weighted-average shares outstanding:
Basic		88,876	91,782	89,079	91,647
Diluted		89,837	92,693	90,146	92,771

[1] Stock-based compensation awards for the issuance of 432 and 328 shares for the second quarter and first six months of 2017 and 848 and 987 shares for the second quarter and first six months 2016, respectively, were excluded from the computation of net income per share on a diluted basis as their effect was anti-dilutive.